NVIDIA is partnering with Schrödinger to harness NVIDIA DGX A100 systems to further expand the speed and accuracy of Schrödinger’s computational drug discovery platform and enable rapid, accurate ...
Collaboration Enables Pharma Industry Giants, Biotech Startups to Use Schrödinger’s Computational Drug Discovery Platform Boosted by NVIDIA DGX SuperPOD and NVIDIA Clara Discovery Libraries SANTA ...
SANTA CLARA, Calif.—GTC—April 12, 2021—NVIDIA today announced a strategic partnership with Schrödinger that harnesses NVIDIA DGX A100 systems to further expand the speed and accuracy of Schrödinger’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback